Vincamine

Vincamine is sold in Europe as a prescription medicine for the treatment of primary degenerative and vascular dementia. In the United States, it is permitted to be sold as a dietary supplement when labeled for use in adults for six months or less. Most common preparations are in the sustained release tablet forms. ==Chemistry==

Synthesis Tabersonine can be used for semi-synthesis of vincamine. Derivatives Vinpocetine is a synthetic derivative of vincamine used for cerebrovascular diseases and as dietary supplement. Vincamine derivatives have been also studied as anti addictive and antidiabetic agents. ==Research==

It may have nootropic effects. Concerns over long-term use have been documented by the US National Toxicology Program.{{cite web == See also ==